共 50 条
An extremely rare case of small-cell lung cancer harboring variant 2 of the EML4-ALK fusion gene
被引:28
|作者:
Toyokawa, Gouji
[1
]
Takenoyama, Mitsuhiro
[1
]
Taguchi, Kenichi
[2
]
Toyozawa, Ryo
[1
]
Inamasu, Eiko
[1
]
Kojo, Miyako
[1
]
Shiraishi, Yoshimasa
[1
]
Morodomi, Yosuke
[1
]
Takenaka, Tomoyoshi
[1
]
Hirai, Fumihiko
[1
]
Yamaguchi, Masafumi
[1
]
Seto, Takashi
[1
]
Shimokawa, Mototsugu
[3
]
Ichinose, Yukito
[1
]
机构:
[1] Kyushu Natl Canc Ctr, Dept Thorac Oncol, Minami Ku, Fukuoka 8111395, Japan
[2] Kyushu Natl Canc Ctr, Inst Clin Res, Canc Pathol Lab, Fukuoka 8111395, Japan
[3] Kyushu Natl Canc Ctr, Inst Clin Res, Fukuoka 8111395, Japan
来源:
关键词:
Small-cell lung cancer;
Oncogenic driver mutation;
EML4-ALK;
MUTATIONS;
D O I:
10.1016/j.lungcan.2013.05.022
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
Anaplastic lymphoma kinase (ALK) fuses echinoderm microtubule-associated protein-like 4 (EML4) to acquire a transforming activity in lung adenocarcinomas. However, the presence of an EML4-ALK fusion gene in other lung cancer histologies is an extremely rare phenomenon. A 43-year-old female was referred to our department due to dyspnea on effort and left back pain. Computed tomography (CT) showed a large mass in the upper lobe of the left lung and a massive left pleural effusion, while a CT-guided needle biopsy confirmed a diagnosis of small-cell lung cancer (SCLC). Surprisingly, the tumor was genetically considered to harbor the EML4-ALK fusion gene (variant 2). Although the patient underwent two regimens of cytotoxic chemotherapy for SCLC, she died approximately seven months after the administration of first-line chemotherapy. Our analysis of 30 consecutive patients with SCLC for EML4-ALK revealed that two patients, including the current patient and a patient we previously reported, harbored the EML4-ALK fusion gene. (c) 2013 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:487 / 490
页数:4
相关论文